Related Experiment Video
Updated: May 11, 2026
06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Creutzfeldt-Jakob disease.
Thierry Billette de Villemeur1
1Pediatric Neurology Service, Pathologie du Développement, Hôpital Trousseau, Université Pierre et Marie Curie-Paris VI, Paris, France.
Handbook of Clinical Neurology
|April 30, 2013
Summary
Prion diseases like Creutzfeldt-Jakob disease (CJD) are rare in children, transmitted via contamination. These neurodegenerative conditions are fatal, with no specific treatments available.
Area of Science:
- Neurology
- Infectious Diseases
- Pathology
Background:
- Prion diseases are rare neurodegenerative disorders affecting children and young adults.
- Known types include kuru, variant Creutzfeldt-Jakob disease (vCJD), and iatrogenic CJD.
- Transmission occurs through infectious contamination, with distinct origins for each type.
Purpose of the Study:
- To summarize the epidemiology, transmission, and clinical presentation of prion diseases in pediatric populations.
- To highlight the diagnostic challenges and lack of effective treatments for these rare conditions.
Main Methods:
- Review of existing literature on pediatric prion diseases.
- Analysis of transmission routes, incubation periods, and clinical manifestations.
- Discussion of diagnostic limitations and current therapeutic approaches.
Main Results:
- Kuru resulted from ritualistic cannibalism; vCJD from consuming contaminated beef (mad cow disease); iatrogenic CJD from medical procedures (e.g., growth hormone, dura mater grafts).
- Incubation periods range from 4 to 30 years.
- Initial symptoms are neurological (ataxia, oculomotor disturbances, pyramidal signs), progressing to dementia.
- Definitive diagnosis relies on neuropathology; prion detection in vCJD tonsils is possible via immunohistochemistry.
- All forms are invariably fatal with no specific treatment.
Conclusions:
- Pediatric prion diseases, though rare, are severe and fatal neurodegenerative conditions.
- Understanding transmission routes is crucial for prevention.
- Current diagnostic and therapeutic options remain limited, emphasizing the need for further research.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...